<DOC>
	<DOC>NCT00774904</DOC>
	<brief_summary>Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by antihypertensive medication with an angiotensin II-receptor blocker (ARB), especially in subjects with type 2 diabetes in different stage of chronic kidney disease (CKD).</brief_summary>
	<brief_title>Adiponectin and Insulin Resistance in Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensin II Type 1 Receptor Blockers</mesh_term>
	<criteria>Type 2 diabetic nephropathy CKD at stage 1~4 Type 1 diabetes or nondiabetic renal disease An elevated plasma K level.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Diabetic Nephropathy</keyword>
	<keyword>Glucose Metabolism</keyword>
	<keyword>Angiotensin II Type 1 Receptor Blockers</keyword>
</DOC>